Mayo Clinic Names Dr. Matthew R. Callstrom as New President and CEO
His previous leadership roles include interim chief strategy officer and chair of the Department of Radiology at Mayo Clinic in Rochester, Minnesota.
Mayo Clinic has appointed Dr. Matthew R. Callstrom as its next president and chief executive officer, succeeding Dr. Gianrico Farrugia, who plans to retire at the end of 2026. Callstrom will assume the role in January 2027, the health system announced Friday.
Callstrom has spent nearly 25 years with Mayo Clinic and currently serves as medical director for Mayo Clinic Strategy and its AI Program. He is also a member of the health system’s Board of Governors and Board of Trustees.
His previous leadership roles include interim chief strategy officer and chair of the Department of Radiology at Mayo Clinic in Rochester, Minnesota.
Farrugia, who has served as Mayo Clinic’s president and CEO since January 2019, announced his retirement plans in May. Welcoming his successor, he said in a LinkedIn post that Callstrom “knows Mayo Clinic deeply, understands where healthcare is headed and has the vision and experience to build on the progress we have made.”
Farrugia added, “I look forward to all that you and our remarkable, Category-of-One staff at Mayo will accomplish together.”
Focus on AI and Clinical Innovation
In a LinkedIn post, Callstrom said he was “deeply honored” to take on the leadership role, highlighting his longstanding association with the organization and its patient-first approach.
“Since joining, I’ve had the privilege of caring for patients, advancing research and innovation, and working alongside remarkable colleagues across our practice,” Callstrom said on LinkedIn. “My leadership roles in strategy, AI, and development have given me an even broader appreciation for what makes Mayo Clinic so special, and for the responsibility we have to ensure it remains so for generations to come.”
Mayo Clinic highlighted Callstrom’s work in integrating artificial intelligence into patient care. His research and innovation initiatives have included developing tools to improve cancer identification across multiple organs and tissues, including the liver, kidney, bone, lung and soft tissue.
Commenting on the health system’s future priorities, Callstrom said, “Mayo Clinic has always been at its best when we bring the full power of our clinical expertise, science and innovation to the needs of the patient. Now, we have an opportunity to build on that foundation – accelerating the translation of discovery and emerging technologies into better care and extending Mayo Clinic’s impact to more patients, wherever they are."
Mayo Clinic's Investments and Expansion
The leadership transition comes as Mayo Clinic continues to invest in its healthcare infrastructure and research capabilities.
The health system reported $21.5 billion in revenue last year, including a $1.5 billion profit, according to MPR News.
Its philanthropic funding also increased from $700 million in 2024 to approximately $953 million in 2025, according to an S&P Global Ratings analysis published March 30.
Mayo Clinic has also undertaken major infrastructure expansion projects across its campuses. In Phoenix, Arizona, the health system launched a $1.9 billion expansion project last year, expected to add 1.2 million square feet of space. In Florida, it has invested more than $1 billion in its Jacksonville campus over the past decade, doubling its size.
Richard K. Davis, chair of the Mayo Clinic Board of Trustees, cited Callstrom’s experience across patient care, research and innovation.
“His leadership across patient care, research, strategy and innovation, combined with his ability to translate scientific discovery and emerging technology into meaningful advances for patients, prepares him exceptionally well to lead Mayo Clinic into its next chapter,” Davis said in a statement.
Stay tuned for more such updates on Digital Health News